What is a stock summary page? Click here for an overview.
Business Description
Corline Biomedical AB
ISIN : SE0006887451
Compare
Compare
Traded in other countries / regions
CLBIO.Sweden IPO Date
2015-06-03Description
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.92 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 15.03 | |||||
| Beneish M-Score | -3.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.1 | |||||
| 3-Year EBITDA Growth Rate | -46.6 | |||||
| 3-Year EPS without NRI Growth Rate | -21 | |||||
| 3-Year FCF Growth Rate | -1.5 | |||||
| 3-Year Book Growth Rate | -6.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.32 | |||||
| 9-Day RSI | 45.29 | |||||
| 14-Day RSI | 46.49 | |||||
| 3-1 Month Momentum % | 16.25 | |||||
| 6-1 Month Momentum % | 29.07 | |||||
| 12-1 Month Momentum % | -14.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.68 | |||||
| Quick Ratio | 2.68 | |||||
| Cash Ratio | 2.25 | |||||
| Days Sales Outstanding | 76.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.5 | |||||
| Shareholder Yield % | -7.23 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 137.5 | |||||
| Operating Margin % | -134.77 | |||||
| Net Margin % | -237.28 | |||||
| FCF Margin % | -165.08 | |||||
| ROE % | -26.13 | |||||
| ROA % | -23.66 | |||||
| ROIC % | -15.56 | |||||
| 3-Year ROIIC % | -44.21 | |||||
| ROC (Joel Greenblatt) % | -8629.66 | |||||
| ROCE % | -26.09 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 1.65 | |||||
| PS Ratio | 21.29 | |||||
| PB Ratio | 2.69 | |||||
| Price-to-Tangible-Book | 18.18 | |||||
| EV-to-EBIT | -9.8 | |||||
| EV-to-Forward-EBIT | -85.31 | |||||
| EV-to-EBITDA | -9.85 | |||||
| EV-to-Forward-EBITDA | -85.31 | |||||
| EV-to-Revenue | 23.24 | |||||
| EV-to-Forward-Revenue | 5.56 | |||||
| EV-to-FCF | -13.29 | |||||
| Price-to-GF-Value | 1.8 | |||||
| Price-to-Median-PS-Value | 0.31 | |||||
| Price-to-Net-Current-Asset-Value | 18.52 | |||||
| Price-to-Net-Cash | 25 | |||||
| Earnings Yield (Greenblatt) % | -10.2 | |||||
| FCF Yield % | -6.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Corline Biomedical AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 9.775 | ||
| EPS (TTM) (kr) | -1.04 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.06 | ||
| 3-Year Sortino Ratio | 0.11 | ||
| Volatility % | 53.6 | ||
| 14-Day RSI | 46.49 | ||
| 14-Day ATR (kr) | 0.564253 | ||
| 20-Day SMA (kr) | 9.6415 | ||
| 12-1 Month Momentum % | -14.17 | ||
| 52-Week Range (kr) | 5.98 - 13.75 | ||
| Shares Outstanding (Mil) | 24.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Corline Biomedical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Corline Biomedical AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Corline Biomedical AB Frequently Asked Questions
What is Corline Biomedical AB(OSTO:CLBIO)'s stock price today?
The current price of OSTO:CLBIO is kr10.00. The 52 week high of OSTO:CLBIO is kr13.75 and 52 week low is kr5.98.
When is next earnings date of Corline Biomedical AB(OSTO:CLBIO)?
The next earnings date of Corline Biomedical AB(OSTO:CLBIO) is 2025-04-30 Est..
Does Corline Biomedical AB(OSTO:CLBIO) pay dividends? If so, how much?
Corline Biomedical AB(OSTO:CLBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers